Unilateral Biportal Endoscopy Industry Overview
The global unilateral biportal endoscopy market size was valued at USD 776.2 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030.
Increasing demand for minimally invasive or key-hole surgeries for diagnostic and therapeutic purposes is expected to drive the overall growth. Advancements in the field of robotic surgery and visually advanced endoscopic procedures are expected to drive the demand for spinal endoscopic procedures. For instance, in March 2018, Auris Health, Inc. received FDA approval for its new robotic endoscopy system, Monarch Platform. In addition, the growing awareness levels of the benefits of these procedures such as reduced hospitalization, shortened operating time, minimal collateral tissue damage, and quicker recovery are boosting demand and contributing to market development. Emergence of advanced visualization technologies is complementing the growing demand for minimally invasive surgeries and is expected to positively influence the market for unilateral biportal endoscopy over the forthcoming years.
Gather more insights about the market drivers, restrains and growth of the Global Unilateral Biportal Endoscopy Market
Some of these innovations are advanced image-guided technology, flexible radiolucent spinal implants, 3D printing of disc tissue, and bone fusion. The use of computer-assisted image guidance for spine localization is constantly evolving and is delivering real-time image datasets. Moreover, these advancements focus on the development of lesser noninvasive surgical techniques, preservation of motion in the operated spinal segment, minimum postoperative pain and complications, and reduction in recovery time.
In addition, Artificial Intelligence (AI) and machine learning are gaining popularity in the field of spinal surgeries. AI aids in surgical decision-making and running data analysis on image datasets by enhancing the surgeon and endoscopist’s data processing capabilities. The ongoing COVID-19 pandemic has negatively impacted the market, as healthcare systems are undergoing a tremendous burden and have led to significant transformations in the healthcare industry, thereby forcing endoscopy facilities to reduce volumes of elective and non-essential endoscopic procedures. For instance, a survey conducted for endoscopy units across 55 countries by the World Endoscopy Organization between April 2020 and May 2020, reported an 87% reduction in the number of endoscopy procedures.
The ongoing pandemic has caused alterations in the operating room structures, workforce, indications, and pre-op setup. The alarming decline in endoscopic procedures was recorded in emerging economies with developing healthcare facilities. Factors such as shortage of Personal Protective Equipment (PPE) and trained workforce, lack of testing facilities, reduced patient load, and restrictions and lockdowns forced the healthcare facilities to reschedule and prioritize procedures as essential or nonessential. They had to cancel endoscopies in medium-to low-risk patients, which can be attributed to the decreasing revenue share of the market.
The growing number of healthcare facilities such as hospitals, ambulatory surgery centers, and specialty clinics is anticipated to boost the demand for unilateral biportal endoscopies over the forecast period. Furthermore, numerous healthcare professionally-owned and managed ambulatory surgery centers are gaining popularity with endoscopists carrying out minimally invasive surgeries in these outpatient settings. For instance, in Europe, the U.K. had the highest number of hospitals, accounting for 3,186 in 2018 and this number is expected to reach 10,027 hospitals by 2025, growing at a CAGR of 18.0%. Furthermore, countries such as Brazil and South Africa are expected to register a significant increase in the number of hospitals with a CAGR of 10.1% and 11.8%, respectively.
Lastly, the global geriatric population is growing at an alarming pace and is susceptible to spinal deformities and degenerative diseases. According to estimates published by United Nations in 2020, the global geriatric population aged 65 or above in 2019 was nearly 727 million, accounting for 9.3% of the global population, and this number is expected to reach over 1.5 billion by 2050, representing 16.0% of the global population. The prevalence of neck and lower back pain is growing and is estimated to affect over 80% of the global geriatric population. Spinal disorders such as lumbar disc herniation, spondylolisthesis, spinal stenosis, and prolapsed intervertebral disc are being recorded worldwide in the geriatric population.
Browse through Grand View Research’s Medical Devices Industry Research Reports.
- Unilateral Biportal Endoscopy Market – The global unilateral biportal endoscopy market size was valued at USD 776.2 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030.
- Colposcopy Market – The global colposcopy market size was valued at USD 427.0 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030.
Market Share Insights
- April 2021: Erbe Elektromedizin announced the acquisition of a German company, Maxer Endoscopy, a manufacturer of endoscopic systems and instruments.
- June 2017: Olympus introduced 3D surgical endoscope, which is compatible with VISERA ELITE II system. It uses 3D imaging that helps with in depth perception for precision in surgery.
Key Companies profiled:
Some prominent players in the global unilateral biportal endoscopy market include
- Endovision Co. Ltd.
- Karl Storz
- Smith & Nephew
- Stryker Corporation
- CONMED Corporation
- Maxer Endoscopy GmbH
- Joimax GmbH
- Richard Wolf
- Jiangsu Bonss Medical Technology Co. Ltd.
- Kinetix Lifesciences
Order a free sample PDF of the Unilateral Biportal Endoscopy Market Intelligence Study, published by Grand View Research.
